Evaluation of High-Sensitivity C-Reactive Protein and Uric Acid in Vericiguat-Treated Patients with Heart Failure with Reduced Ejection Fraction

Vericiguat treatment for 12 weeks was associated with reductions in hsCRP and SUA, and a higher likelihood of achieving an hsCRP value of ≤3.0 mg/L and SUA value of <7.0 mg/dL.